Srinivas, Upadhyayula S.
Tay, Norbert S. C. http://orcid.org/0000-0002-4960-9250
Jaynes, Patrick
Anbuselvan, Akshaya
Ramachandran, Gokula K.
Wardyn, Joanna D.
Hoppe, Michal M. http://orcid.org/0000-0002-0364-6080
Hoang, Phuong Mai
Peng, Yanfen http://orcid.org/0000-0003-1753-8547
Lim, Sherlly
Lee, May Yin http://orcid.org/0000-0003-2366-9463
Peethala, Praveen C.
An, Omer http://orcid.org/0000-0002-5762-6253
Shendre, Akshay
Tan, Bryce W. Q.
Jemimah, Sherlyn
Lakshmanan, Manikandan
Hu, Longyu
Jakhar, Rekha
Sachaphibulkij, Karishma
Lim, Lina H. K.
Pervaiz, Shazib http://orcid.org/0000-0002-4738-019X
Crasta, Karen
Yang, Henry
Tan, Patrick
Liang, Chao
Ho, Lena
Khanchandani, Vartika http://orcid.org/0000-0002-9331-3051
Kappei, Dennis http://orcid.org/0000-0002-3582-2253
Yong, Wei Peng
Tan, David S. P.
Bordi, Matteo
Campello, Silvia http://orcid.org/0000-0003-0536-2484
Tam, Wai Leong http://orcid.org/0000-0003-2365-5264
Frezza, Christian http://orcid.org/0000-0002-3293-7397
Jeyasekharan, Anand D. http://orcid.org/0000-0001-9816-6137
Article History
Received: 16 June 2021
Revised: 12 January 2022
Accepted: 27 January 2022
First Online: 2 March 2022
Change Date: 6 May 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41388-022-02338-2
Competing interests
: ADJ: honoraria from Turbine Ltd, AstraZeneca, Antengene, Janssen and MSD, travel funding from Perkin Elmer, and research funding from Janssen and AstraZeneca. DSPT: honoraria from AstraZeneca, Roche, Bayer, MSD, Merck Serono, Tessa Therapeutics, Novartis, and Genmab and research funding from AstraZeneca, Bayer and Karyopharm. The other co-authors have no conflicts of interest to declare.